The interesting fact that BRAF inhibition in 8505C cells induces EMT from our study suggests that sustained BRAF inhibitor treatment in thyroid cancer would do more harm than good, which raises an important clinical issue. The gene discussed is BRAF; the disease is thyroid gland carcinoma.